Literature DB >> 7977726

Regulation of ACE gene expression and plasma levels during rat postnatal development.

O Costerousse1, J Allegrini, H Huang, J Bounhik, F Alhenc-Gelas.   

Abstract

Angiotensin I-converting enzyme (kininase II, ACE) is a transmembrane ectoenzyme of vascular endothelial cells that is also secreted in plasma. To understand why plasma ACE levels are elevated in children compared with adults, the age-related changes in ACE mRNA and enzyme levels were studied in 1-day- to 3-mo-old rats. In the lung, a rich source of endothelial ACE, the abundance of ACE mRNA and the microsomal ACE concentration increased progressively and tripled during the first 3 mo. This large increase reflects, at least in part, development of the capillary network. In plasma, ACE levels rose dramatically a few days after birth and decreased toward adult values after the 14th day of life. Because the elevation of ACE in plasma was contemporary to thyroid maturation, the effect of perinatal suppression of thyroid function by propylthiouracil was studied. Hypothyroidism slightly delayed the evolution of ACE in lung but blunted the postnatal rise in plasma ACE levels. A 3,5,3'-triiodothyronine injection to 14-day-old hypothyroid rats failed to alter ACE mRNA levels in the lung. Thus thyroid hormones are involved in the postnatal rise in plasma ACE levels but act probably on the posttranslational proteolytic pathway involved in ACE secretion by endothelial cells or on an unknown extrapulmonary ACE source. ACE gene expression is also developmentally regulated in epithelia and male germinal cells. In the intestine, ACE mRNA levels and ACE activity were very high at birth and then decreased dramatically during the next 2 wk. In the kidney, they were low and decreased further during growth.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7977726     DOI: 10.1152/ajpendo.1994.267.5.E745

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  6 in total

1.  The urinary activity of angiotensin-converting enzyme in preterm, full-term newborns, and children.

Authors:  Graziela Lopes Del Ben; Beata Marie Redublo Quinto; Dulce Elena Casarini; Luiz Carlos Bueno Ferreira; Sérgio Sousa Ayres; João Tomás de Abreu Carvalhaes
Journal:  Pediatr Nephrol       Date:  2006-06-30       Impact factor: 3.714

2.  Genetically increased angiotensin I-converting enzyme level and renal complications in the diabetic mouse.

Authors:  W Huang; Y Gallois; N Bouby; P Bruneval; D Heudes; M F Belair; J H Krege; P Meneton; M Marre; O Smithies; F Alhenc-Gelas
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-30       Impact factor: 11.205

3.  Role of cortisol in the ontogenic control of pulmonary and renal angiotensin-converting enzyme in fetal sheep near term.

Authors:  A J Forhead; C E Gillespie; A L Fowden
Journal:  J Physiol       Date:  2000-07-15       Impact factor: 5.182

4.  ACE inhibition reduces infarction in normotensive but not hypertensive rats: correlation with cortical ACE activity.

Authors:  Michelle J Porritt; Michelle Chen; Sarah S J Rewell; Rachael G Dean; Louise M Burrell; David W Howells
Journal:  J Cereb Blood Flow Metab       Date:  2010-04-21       Impact factor: 6.200

5.  Genetically determined angiotensin converting enzyme level and myocardial tolerance to ischemia.

Authors:  Erij Messadi; Marie-Pascale Vincent; Violaine Griol-Charhbili; Chantal Mandet; Juliana Colucci; John H Krege; Patrick Bruneval; Nadine Bouby; Oliver Smithies; François Alhenc-Gelas; Christine Richer
Journal:  FASEB J       Date:  2010-07-28       Impact factor: 5.191

6.  Predictive potential of ACE phenotyping in extrapulmonary sarcoidosis.

Authors:  Sergei M Danilov; Olga V Kurilova; Valentin E Sinitsyn; Armais A Kamalov; Joe G N Garcia; Steven M Dudek
Journal:  Respir Res       Date:  2022-08-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.